Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
暂无分享,去创建一个
P. Isaakidis | M. Das | H. Mansoor | A. Andries | P. Saranchuk | A. Deshpande | Samsuddin Khan | Aristomo Andries
[1] UP Ghaziabad. MINISTRY OF HEALTH & FAMILY WELFARE GOVERNMENT OF INDIA , 2016 .
[2] S. Pujari,et al. Short-Term Effectiveness and Safety of Third-Line Antiretroviral Regimens Among Patients in Western India , 2014, Journal of acquired immune deficiency syndromes.
[3] N. Ford,et al. High rate of virological re-suppression among patients failing second-line antiretroviral therapy following enhanced adherence support: A model of care in Khayelitsha, South Africa , 2013 .
[4] C. Colvin,et al. Perceived adherence barriers among patients failing second-line antiretroviral therapy in Khayelitsha, South Africa , 2013 .
[5] M. Peeters,et al. Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon , 2013, Journal of the International AIDS Society.
[6] G. Sotgiu,et al. Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India , 2012, PloS one.
[7] N. Ford,et al. Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis , 2012, AIDS.
[8] S. Hammer,et al. Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] T. F. Rinke de Wit,et al. Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa , 2011, Journal of acquired immune deficiency syndromes.
[10] A. Calmy,et al. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries. , 2010, JAMA.
[11] Nirman Bhavan,et al. Government of India Ministry of Health & Family Welfare , 2010 .
[12] Ray Y. Chen,et al. Five-Year Outcomes of the China National Free Antiretroviral Treatment Program , 2009, Annals of Internal Medicine.
[13] D. Bennett,et al. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance , 2008, Antiviral therapy.
[14] D. Bennett,et al. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites , 2008, Antiviral therapy.
[15] D. Bennett,et al. Darunavir: pharmacokinetics and drug interactions. , 2008 .
[16] B. Stilwell,et al. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. , 2006 .
[17] C. Dolea,et al. World Health Organization , 1949, International Organization.